Stock Detail
SCOLR PHARMA INC
Diagnostic Substances
DDD @ Yahoo Finance | DDD Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $16.82 | $17.29 | $0.19 | 1.14% | 0.11 | $16.63 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $16.64 | $16.34 | 396,624 | 850.06M | 520,924 | 22.82 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 17.77 | 17.30 | 16.82 | 16.35 | 15.87 |
Stock Profile
SCOLR Pharma, Inc., a drug delivery company, engages in the development and formulation of over-the-counter products, prescription drugs, and nutraceutical products that use its patented controlled delivery technology (CDT). It uses CDT platform to develop products and license technology to pharmaceutical and nutritional product companies. The company's products include Ibuprofen, for analgesic; Pseudoephedrine, a drug for decongestion; Raloxifene, for osteoporosis; Niacin, for cardiac; and Tramadol, an analgesic drug. SCOLR has strategic alliance with Archer-Daniels-Midland Company for the development of certain CDT-based dietary supplement and nutraceutical products. The company was incorporated in 1994 under the name Caddy Systems, Inc. and changed its name to Nutraceutix, Inc. in 1995. Further, it changed name to SCOLR, Inc. in 2002 and to SCOLR Pharma, Inc. in 2004. SCOLR is headquartered in Bellevue, Washington.